Neos Therapeutics (NEOS) Stock Price, Quote, News and Overview

What is the stock price of Neos Therapeutics today?

The current stock price of NEOS is 1.15 null. The price decreased by -2.54% in the last trading session.

What is the ticker symbol for Neos Therapeutics stock?

The exchange symbol of Neos Therapeutics is NEOS and it is listed on the Nasdaq exchange.

On which exchange is NEOS stock listed?

NEOS stock is listed on the Nasdaq exchange.

What is Neos Therapeutics worth?

Neos Therapeutics (NEOS) has a market capitalization of 57.22M null. This makes NEOS a Micro Cap stock.

What are the support and resistance levels for Neos Therapeutics (NEOS) stock?

Neos Therapeutics (NEOS) has a support level at 0.81. Check the full technical report for a detailed analysis of NEOS support and resistance levels.

Should I buy Neos Therapeutics (NEOS) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:

• The Technical Analysis (TA) tab contains a technical analysis of NEOS, looking at technical quality and support and resistance levels
• The Fundamental Analysis (FA) tab contains a fundamental analysis of NEOS, evaluating the profitability, health, valuation and growth aspects
• Neos Therapeutics (NEOS) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
• Neos Therapeutics (NEOS) Sales and EPS estimates to see what analysts future expectations are.
• Neos Therapeutics (NEOS) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
• Neos Therapeutics (NEOS) Insider and Institutional Ownership to learn about the owners and their transactions.
• Neos Therapeutics (NEOS) Stock Chart to make your own analysis
• Neos Therapeutics (NEOS) Latest news and press-releases to stay up to date.

Does Neos Therapeutics (NEOS) stock pay dividends?

NEOS does not pay a dividend.

What is the Price/Earnings (PE) ratio of Neos Therapeutics (NEOS)?

Neos Therapeutics (NEOS) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.44).

ChartMill assigns a fundamental rating of 3 / 10 to NEOS. NEOS may be in some trouble as it scores bad on both profitability and health.

Over the last trailing twelve months NEOS reported a non-GAAP Earnings per Share(EPS) of -0.44. The EPS increased by 12% compared to the year before.

ChartMill assigns a Buy % Consensus number of 100% to NEOS. The Buy consensus is the average rating of analysts ratings from 1 analysts.